These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 19692277)

  • 1. Low-dose acyclovir against reactivation of varicella zoster virus after unrelated cord blood transplantation.
    Uchiyama M; Tamai Y; Ikeda T
    Int J Infect Dis; 2010 May; 14(5):e451-2. PubMed ID: 19692277
    [No Abstract]   [Full Text] [Related]  

  • 2. Long-term low-dose acyclovir against varicella-zoster virus reactivation after allogeneic hematopoietic stem cell transplantation.
    Kanda Y; Mineishi S; Saito T; Saito A; Yamada S; Ohnishi M; Chizuka A; Niiya H; Suenaga K; Nakai K; Takeuchi T; Makimoto A; Tanosaki R; Kami M; Tanaka Y; Fujita S; Watanabe T; Kobayashi Y; Tobinai K; Takaue Y
    Bone Marrow Transplant; 2001 Oct; 28(7):689-92. PubMed ID: 11704792
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term ultra-low-dose acyclovir against varicella-zoster virus reactivation after allogeneic hematopoietic stem cell transplantation.
    Asano-Mori Y; Kanda Y; Oshima K; Kako S; Shinohara A; Nakasone H; Sato H; Watanabe T; Hosoya N; Izutsu K; Asai T; Hangaishi A; Motokura T; Chiba S; Kurokawa M
    Am J Hematol; 2008 Jun; 83(6):472-6. PubMed ID: 18266207
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prophylactic role of long-term ultra-low-dose acyclovir for varicella zoster virus disease after allogeneic hematopoietic stem cell transplantation.
    Kawamura K; Wada H; Yamasaki R; Ishihara Y; Sakamoto K; Ashizawa M; Sato M; Machishima T; Terasako K; Kimura S; Kikuchi M; Nakasone H; Yamazaki R; Kanda J; Kako S; Tanihara A; Nishida J; Kanda Y
    Int J Infect Dis; 2014 Feb; 19():26-32. PubMed ID: 24211377
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical efficacy of prophylactic strategy of long-term low-dose acyclovir for Varicella-Zoster virus infection after allogeneic peripheral blood stem cell transplantation.
    Kim DH; Kumar D; Messner HA; Minden M; Gupta V; Kuruvilla J; Chae YS; Sohn SK; Lipton JH
    Clin Transplant; 2008; 22(6):770-9. PubMed ID: 18707605
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of low-dose aciclovir on reactivation of varicella zoster virus after allogeneic haemopoietic stem cell transplantation.
    Thomson KJ; Hart DP; Banerjee L; Ward KN; Peggs KS; Mackinnon S
    Bone Marrow Transplant; 2005 Jun; 35(11):1065-9. PubMed ID: 15806119
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Varicella-zoster virus infection under administration of ganciclovir after allogeneic bone marrow transplantation.
    Mori T; Shimizu T; Yamazaki R; Aisa Y; Nakazato T; Ikeda Y; Okamoto S
    Scand J Infect Dis; 2006; 38(3):227-8. PubMed ID: 16500790
    [No Abstract]   [Full Text] [Related]  

  • 8. Visceral varicella zoster virus (VZV) after allogeneic hematopoietic stem cell transplant (HSCT) in pediatric patients with chronic graft-versus-host disease (cGVHD).
    Peritz DC; Duncan C; Kurek K; Perez-Atayde AR; Lehmann LE
    J Pediatr Hematol Oncol; 2008 Dec; 30(12):931-4. PubMed ID: 19131784
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Varicella zoster virus reactivation in hemodialysis patients: manifestations, treatment, complications and outcome.
    Mesar I; Basić-Jukić N; Hudolin T; Katalinić L; Kes P
    Acta Clin Croat; 2011 Dec; 50(4):549-52. PubMed ID: 22649885
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical features and risk factors for developing varicella zoster virus dissemination following hematopoietic stem cell transplantation.
    Umezawa Y; Kakihana K; Oshikawa G; Kobayashi T; Doki N; Sakamaki H; Ohashi K
    Transpl Infect Dis; 2014 Apr; 16(2):195-202. PubMed ID: 24438510
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevention of VZV infection in immunosuppressed patients using antiviral agents.
    Boeckh M
    Herpes; 2006 Nov; 13(3):60-5. PubMed ID: 17147908
    [TBL] [Abstract][Full Text] [Related]  

  • 12. One-year acyclovir prophylaxis for preventing varicella-zoster virus disease after hematopoietic cell transplantation: no evidence of rebound varicella-zoster virus disease after drug discontinuation.
    Erard V; Guthrie KA; Varley C; Heugel J; Wald A; Flowers ME; Corey L; Boeckh M
    Blood; 2007 Oct; 110(8):3071-7. PubMed ID: 17515400
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of the duration of antiviral prophylaxis on rates of varicella-zoster virus reactivation disease in autologous hematopoietic cell transplantation recipients.
    Truong Q; Veltri L; Kanate AS; Hu Y; Craig M; Hamadani M; Cumpston A
    Ann Hematol; 2014 Apr; 93(4):677-82. PubMed ID: 24097085
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prophylactic antivirals may be helpful in prevention of varicella-zoster virus reactivation in myeloma, but are they safe?
    Dasanu CA; Alexandrescu DT
    J Oncol Pharm Pract; 2010 Dec; 16(4):266-8. PubMed ID: 19965947
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Varicella-zoster reactivation after allogeneic stem cell transplantation without routine prophylaxis--the incidence remains high.
    Blennow O; Fjaertoft G; Winiarski J; Ljungman P; Mattsson J; Remberger M
    Biol Blood Marrow Transplant; 2014 Oct; 20(10):1646-9. PubMed ID: 24914821
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effectiveness of acyclovir prophylaxis against varicella zoster virus disease after allogeneic hematopoietic cell transplantation: A systematic review and meta-analysis.
    Wada-Shimosato Y; Tanoshima R; Hiratoko K; Takeuchi M; Tsujimoto SI; Shiba N; Ito S; Yamanaka T; Ito S
    Transpl Infect Dis; 2019 Jun; 21(3):e13061. PubMed ID: 30756465
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Herpes zoster triplex.
    Takashima S; Ota M
    Cleve Clin J Med; 2015 Sep; 82(9):579. PubMed ID: 26366954
    [No Abstract]   [Full Text] [Related]  

  • 18. Daily 500 mg valacyclovir is effective for prevention of Varicella zoster virus reactivation in patients with multiple myeloma treated with bortezomib.
    Fukushima T; Sato T; Nakamura T; Iwao H; Nakajima A; Miki M; Sakai T; Kawanami T; Sawaki T; Fujita Y; Tanaka M; Masaki Y; Okazaki T; Nakajima H; Motoo Y; Umehara H
    Anticancer Res; 2012 Dec; 32(12):5437-40. PubMed ID: 23225448
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acyclovir to prevent reactivation of varicella zoster virus (herpes zoster) in multiple myeloma patients receiving bortezomib therapy.
    Vickrey E; Allen S; Mehta J; Singhal S
    Cancer; 2009 Jan; 115(1):229-32. PubMed ID: 19090004
    [TBL] [Abstract][Full Text] [Related]  

  • 20. C3-C4 shingles post haematopoietic stem-cell transplantation.
    Connor S; O'Brien M; Irvine A; O'Marcaigh A; Smith O
    Arch Dis Child; 2015 Feb; 100(2):137. PubMed ID: 25187495
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.